STOCK TITAN

Wrap Technologies, Inc. Form 4 Filings

WRAP NASDAQ

Every Form 4 that Wrap Technologies, Inc. (WRAP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow WRAP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WRAP filings page.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. (symbol: WRAP) is the issuer of record for a Form 4 filing submitted to the SEC. Cohen Scot reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. (WRAP) reported that Executive Chairman and CEO, and ten percent owner, Scot Cohen had Common Stock credited on September 4, 2026 as stock dividends on Series A Convertible Preferred Stock. He received 19,532 shares directly and 27,344 shares indirectly through V4 Global LLC, both at no cash price as they were issued as dividend payments. Following these transactions, Cohen directly holds 10,609,087 shares, with an additional 2,042,221 shares held indirectly through V4 Global LLC and 209,353 shares held indirectly through the Scot Cohen Roth IRA.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. (WRAP) received an amended Form 4 from Executive Chairman and CEO Scot Cohen, who is also a ten percent owner, to correct and clarify his indirect beneficial holdings of common stock. The amendment states that 209,353 shares are held through the Scot Cohen Roth IRA and 2,014,877 shares are held through V4 Global LLC, with Cohen deemed a beneficial owner only to the extent of his pecuniary interest. The filing reports these indirect positions and does not show new purchases or sales of WRAP stock.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. (WRAP) filed an amended Form 4 to correct how certain common stock holdings are reported for President and COO Jared Novick. The amendment states that 275,000 shares of common stock are held indirectly through Continuum Ventures, LLC, rather than the previously reported entity.

The shares are directly owned by Continuum Ventures, LLC and may be deemed beneficially owned by Jared Novick as its managing member, although he disclaims beneficial ownership except to the extent of his pecuniary interest. No new purchases, sales, or option exercises are reported, and no Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. (symbol: WRAP) is the issuer of record for a Form 4 filing submitted to the SEC. Novick Jared reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. reported that President and COO Jared Novick received a grant of 2,000,000 shares of restricted common stock on September 2, 2026. The award carries voting and dividend rights from grant and vests in four 500,000‑share tranches upon achieving specified market capitalization targets sustained over 45 consecutive trading days, ranging from $150 million up to $506.25 million. If stockholder approval of an increase in shares reserved under the Wrap Technologies, Inc. 2017 Equity Compensation Plan is not obtained by March 15, 2027, 800,000 of these restricted shares will be forfeited. After the grant, Novick is reported to hold 2,153,012 shares directly and 275,000 shares indirectly through a Scot Cohen Roth IRA.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. (symbol: WRAP) is the issuer of record for a Form 4 filing submitted to the SEC. Cohen Scot reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. (WRAP) reported that Executive Chairman and CEO, and more than 10% owner, Scot Cohen received a grant of 4,000,000 shares of restricted common stock on September 2, 2026. These shares have voting and dividend rights but vest only if specified market capitalization hurdles are met over 45 consecutive trading days at levels of $150 million, $225 million, $337.5 million, and $506.25 million, 1,000,000 shares tied to each hurdle. If stockholder approval to increase shares reserved under the 2017 Equity Compensation Plan is not obtained by March 15, 2027, 1,600,000 of these restricted shares are forfeited. After this award, Cohen holds 10,589,555 shares directly and 209,353 shares indirectly through Continuum Ventures, LLC.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. insider Scot Cohen, Executive Chairman, CEO and more than ten percent owner, filed an amended Form 4 to correct a prior report. The amendment states that on July 8, 2026, an IRA associated with him purchased 209,353 shares of common stock at $1.10 per share in an open-market transaction, rather than 21,740 shares as originally reported, and clarifies that these shares are held indirectly through the Scot Cohen Roth IRA. A separate line shows he also holds 6,589,555 common shares directly as of July 7, 2026.

Rhea-AI Summary

WRAP Technologies director John D. Shulman reported an open-market purchase of 100,000 shares of common stock at $1.10 per share. After this transaction, he directly owns 199,037 shares of WRAP common stock. A separate line in the filing shows 250,000 shares held indirectly through Juggernaut Management, LLC, which directly owns those securities; they may be deemed beneficially owned by Shulman as manager of Juggernaut, though he disclaims beneficial ownership except to the extent of his pecuniary interest.

Rhea-AI Summary

WRAP Technologies Executive Chairman and CEO Scot Cohen reported multiple share acquisitions. On July 8, 2026, he made an open-market purchase of 21,740 shares of common stock at $1.10 per share, bringing his direct holdings to 6,798,908 shares.

On July 7, 2026, he also acquired 4,576 common shares directly and 6,408 common shares indirectly through V4 Global LLC as stock issued as payment of dividends on Series A Convertible Preferred Stock. Following these awards, V4 Global LLC held 2,014,877 shares that may be deemed beneficially owned by Cohen to the extent of his pecuniary interest.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director Bruce Bernstein received a grant of stock options covering 34,998 shares of common stock. The options have an exercise price of $1.45 per share and expire on July 1, 2036. Following this award, he holds 34,998 derivative securities directly.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director Marc Savas reported receiving a stock option grant covering 34,998 shares of Common Stock. The option has an exercise price of $1.45 per share, was granted on July 1, 2026, and is scheduled to expire on July 1, 2036. Following this grant, he holds 34,998 derivative securities directly.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director Rajiv Srinivasan received a grant of stock options as part of his compensation. On July 1, 2026, he was awarded options to acquire 34,998 shares of common stock at an exercise price of $1.45 per share, expiring on July 1, 2036. These options are held directly and represent an acquisition of derivative securities rather than an open-market stock purchase or sale.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director Timothy Szymanski reported a grant of stock options giving the right to buy 34,998 shares of common stock. The options have an exercise price of $1.45 per share and expire on July 1, 2036. This is a compensation-related award, not an open-market trade, and leaves him holding 34,998 derivative securities after the grant.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director John D. Shulman received a grant of stock options covering 34,998 shares of common stock. The options have an exercise price of $1.45 per share, were granted on July 1, 2026, and expire on July 1, 2036. Following this grant, Shulman holds 34,998 stock options directly.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. Executive Chairman and CEO Scot Cohen reported acquiring additional common shares through stock dividends rather than market purchases. On the reported date, he received 21,740 shares of common stock directly as payment of dividends on Series A Convertible Preferred Stock.

An affiliated entity, V4 Global LLC, received a further 30,435 common shares as dividend payment, which may be deemed beneficially owned by Cohen as V4’s managing member, though he disclaims beneficial ownership beyond his pecuniary interest. Following these transactions, Cohen directly held 6,584,979 shares, and V4 Global LLC held 2,008,469 shares of common stock.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. insider Elwood G Norris, a ten percent owner, reported a series of indirect open-market sales of common stock held by a Family Trust. Between February 2 and February 10, 2026, the trust sold a total of 189,095 shares at prices around $1.82–$2.20 per share. After these transactions, the trust continued to hold 5,113,938 shares of WRAP common stock indirectly attributed to Norris.

Rhea-AI Summary

SHULMAN JOHN D reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. director John D. Shulman reported an equity grant in the form of restricted stock units (RSUs). He received 19,643 shares of common stock at a price of $0.00 per share as a grant or award, rather than an open‑market purchase.

According to the footnotes, 12,768 of these RSUs vested on the grant date, and the remaining units vest in eight equal monthly tranches. After this grant, he holds 99,037 shares directly and 250,000 shares indirectly through Juggernaut Management, LLC, an entity associated with him where he may be deemed to have a pecuniary interest.

Rhea-AI Summary

Szymanski Timothy reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. director Timothy Szymanski received a grant of 19,643 shares of Common Stock in the form of Restricted Stock Units at a stated price of $0.00 per share. Following this award, he directly holds 156,859 shares.

According to the grant terms, 12,768 of the RSUs vested on the grant date, and the remaining units vest in eight equal monthly tranches, creating a short, time-based vesting schedule tied to continued service.

Rhea-AI Summary

Srinivasan Rajiv reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. director Rajiv Srinivasan reported an equity compensation grant of 19,643 shares of Common Stock in the form of Restricted Stock Units. The grant was made at no cash cost per share.

According to the footnote, 12,763 of these RSUs vested on the grant date, and the remaining units vest in eight equal monthly installments. Following this award, Srinivasan directly holds 164,750 shares of WRAP common stock.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. director Marc Savas reported an acquisition of company stock through an equity award. He received 19,643 shares of Common Stock as a grant valued at $0.0000 per share, structured as Restricted Stock Units (RSUs). On the grant date, 12,768 RSUs vested, with the remaining units scheduled to vest in eight equal monthly installments. After this award, Savas directly holds 242,856 shares of WRAP common stock. Separately, 75,000 shares are held indirectly through Savbo Investments LLC, which may be deemed beneficially owned by him as its Chief Executive Officer, subject to his stated pecuniary interest.

Rhea-AI Summary

Bernstein Bruce reported acquisition or exercise transactions in this Form 4 filing.

WRAP TECHNOLOGIES, INC. director Bruce Bernstein received a grant of 19,643 shares of common stock in the form of Restricted Stock Units on April 1, 2026. According to the terms, 12,768 RSUs vested on the grant date and the remaining RSUs vest in eight equal monthly tranches. Following this award, he directly holds 250,848 shares of WRAP common stock.

Rhea-AI Summary

WRAP TECHNOLOGIES, INC. Executive Chairman and CEO Scot Cohen reported routine share awards tied to preferred stock dividends. On dividend payment in kind, an entity associated with him, V4 Global LLC, acquired 4,763 shares of common stock, and he directly acquired 3,402 shares, both at no cash cost.

Following these transactions, Cohen’s indirect holdings through V4 Global LLC increased to 1,978,034 common shares, while his direct holdings rose to 6,563,239 common shares. No open‑market purchases or sales were reported, and no derivative securities remain disclosed in this filing.

Rhea-AI Summary

WRAP Technologies Executive Chairman and CEO Scot Cohen reported stock acquisitions on Form 4. On March 4, 2026, an entity called V4 Global LLC received 38,740 shares of common stock, issued as a dividend payment on Series A Convertible Preferred Stock. These securities are directly owned by V4 Global LLC and may be deemed beneficially owned by Cohen as its managing member, although he disclaims beneficial ownership except for his pecuniary interest.

On the same date, Cohen also reported a separate grant or award acquisition of 27,672 shares of common stock held directly. After this direct transaction, his direct holdings totaled 6,559,837 shares of common stock.

Rhea-AI Summary

Wrap Technologies Executive Chairman and CEO Scot Cohen, also a director and 10% owner, reported multiple equity transactions. Through V4 Global LLC, an entity associated with him, 475,000 shares of common stock were purchased from Wrap Technologies at $2 per share in a private placement, and 60,345 additional shares were issued as stock dividends on Series A Convertible Preferred Stock. Cohen also received 43,104 dividend shares directly.

Separately, a Roth IRA associated with Cohen acquired 475,000 PIPE warrants exercisable for common stock at $2.30 per share, subject to adjustment. Cohen was also granted 2,000,000 stock options with an exercise price of $2.18 per share, 25% vesting on the grant date and the remainder vesting annually over three years, with potential accelerated vesting if specified market capitalization milestones are achieved while he continues in service.

Rhea-AI Summary

WRAP Technologies granted President and COO Jared Novick stock options to buy 1,000,000 shares of common stock at an exercise price of $2.18 per share on 02/01/2026.

The options expire on 02/01/2036. According to the terms, 25% of the options vested immediately on the grant date, and the remaining 75% will vest in three equal annual installments. Unvested options may vest faster if certain market capitalization milestones are achieved, but in all cases Novick must be employed or providing services to WRAP on each applicable vesting date.

Rhea-AI Summary

Wrap Technologies director Bruce Bernstein reported a new stock option grant. On February 1, 2026, he received a stock option to buy 100,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.

According to the filing, 33,000 options vested immediately on the grant date. The remaining options will vest in three equal annual tranches, as long as Bernstein continues to be employed by or provide services to the company on each vesting date. After this grant, he beneficially owns 100,000 derivative securities directly.

Rhea-AI Summary

Juggernaut Management, LLC, an entity associated with WRAP director John D. Shulman, acquired 250,000 shares of common stock at $2.00 per share and 250,000 warrants with a $2.30 exercise price in a private placement on February 2, 2026.

The warrants can be exercised into 250,000 WRAP common shares and their exercise price is adjustable if the company issues stock or convertible securities below $2.30. Following these transactions, Shulman also directly owned 79,394 WRAP common shares.

Rhea-AI Summary

Wrap Technologies director Marc Savas reported new indirect and direct holdings in the company’s stock. Savbo Investments LLC, of which he is Chief Executive Officer, acquired 25,000 shares of common stock from Wrap Technologies at $2 per share in a private placement under a Securities Purchase Agreement dated February 2, 2026.

Savbo Investments LLC also acquired 25,000 PIPE warrants with an exercise price of $2.30 per share, exercisable from February 3, 2026 until February 3, 2031, with the exercise price subject to adjustment if certain lower-priced issuances occur. Following these transactions, Savas indirectly owns 75,000 shares through Savbo Investments LLC and directly owns 223,213 shares of Wrap Technologies common stock.

Rhea-AI Summary

Wrap Technologies director Rajiv Srinivasan reported a new stock option grant. On February 1, 2026, he received a stock option to buy 50,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.

According to the filing, 16,500 options vested on the grant date, and the remaining options will vest ratably in three annual tranches thereafter, provided that he is employed or providing services to the company on each vesting date. After this grant, he beneficially owns 50,000 derivative securities directly.

Rhea-AI Summary

Wrap Technologies insider activity: A family trust associated with 10% owner Elwood G. Norris reported two open-market sales of WRAP common stock. On January 28, 2026, the trust sold 68,020 shares at a weighted average price of $2.4619, and on January 29, 2026 it sold 80,000 shares at a weighted average price of $2.207. The prices reflect multiple trades in ranges from $2.44–$2.52 and $2.14–$2.26, respectively. After these transactions, the trust indirectly held 5,303,033 WRAP shares.

Rhea-AI Summary

Wrap Technologies 10% owner Elwood G. Norris reported sustained open-market stock sales over several months in 2025. The Form 4 shows multiple sales of Wrap Technologies common stock between June 13, 2025, and November 28, 2025, at prices generally ranging from about $1.50 to $2.91 per share, often reported as weighted-average prices across numerous trades.

After the latest reported sale of 5,000 shares at $2.153 on November 28, 2025, Norris directly held 54,928 shares. Earlier, on June 13, 2025, he directly held 859,339 shares. In addition to his direct holdings, he is shown as indirectly beneficially owning 5,451,053 shares of common stock through a family trust.

Rhea-AI Summary

Wrap Technologies, Inc. director Marc Savas reported an equity award linked to the company’s common stock on January 12, 2026. The transaction covers 7,063 shares at a stated price of $0.00, reflecting a grant rather than an open-market purchase. According to the footnote, this represents a grant of Restricted Stock Units, with 2,119 RSUs vesting on the grant date and the remaining units vesting in eleven equal monthly installments. After this award, Savas is shown as beneficially owning 223,213 shares of Wrap Technologies common stock directly.

Rhea-AI Summary

WRAP Technologies director Rajiv Srinivasan reported an equity award of 3,346 shares of common stock through a grant of restricted stock units (RSUs). The award was recorded at a price of $0 per share, reflecting that it is a compensatory grant rather than an open‑market purchase.

According to the terms, 1,004 of the RSUs vested on the January 12, 2026 grant date, and the remaining units vest in eleven equal monthly tranches. After this grant, Srinivasan beneficially owns 145,107 shares of WRAP common stock directly.

Rhea-AI Summary

Wrap Technologies director Bruce Bernstein reported a stock grant. On January 12, 2026, he acquired 10,409 shares of common stock at a price of $0 per share, reported as an award of restricted stock units (RSUs). According to the filing, 3,123 RSUs vested on the grant date, and the remaining units vest in eleven equal monthly installments. After this grant, Bernstein beneficially owns 231,205 shares of Wrap Technologies common stock, held as direct ownership.

Rhea-AI Summary

Bruce Bernstein, a director of Wrap Technologies, Inc. (WRAP), reported a grant of 13,940 Restricted Stock Units (RSUs) on 10/01/2025 tied to his board service for the quarter ended 9/30/2025. The filing shows 9,061 of those RSUs vested on the grant date and the remaining RSUs will vest ratably in eight monthly tranches. The transaction was recorded with a grant price of $0, and after the award the reporting person beneficially owns 208,086 shares of common stock. The Form 4 is signed and dated 10/08/2025.

Rhea-AI Summary

WRAP Technologies, Inc. director Timothy Szymanski reported a grant of 13,940 Restricted Stock Units (RSUs) on 10/01/2025 related to board service for the quarter ended 9/30/2025. On the grant date 9,061 RSUs vested immediately; the remainder vests ratably in eight monthly tranches. The filing shows 124,506 shares beneficially owned by the reporting person after the grant. The reported grant has a $0 per‑share price because it represents RSUs, not a purchased security. The form is a routine Section 16 filing documenting an equity award and the subsequent vesting schedule for an officer/director.

Rhea-AI Summary

Reporting person: Marc Savas, a director of WRAP Technologies, Inc. (WRAP), reported a grant of 13,940 restricted stock units (RSUs) on 10/01/2025 tied to Board service for the quarter ended 9/30/2025. On the grant date 9,061 RSUs vested immediately while the remainder will vest ratably in eight monthly tranches. After the transaction the reporting person beneficially owned 203,440 shares of common stock. The form is filed as an individual Form 4 and is signed by Marc Savas on 10/08/2025.

Rhea-AI Summary

Reporting person: Rajiv Srinivasan, a director of Wrap Technologies, Inc. (WRAP), reported a grant of 13,940 restricted stock units (RSUs) on 10/01/2025. The filing shows 9,061 RSUs vested on the grant date and the remaining RSUs vest ratably in eight monthly tranches, creating a near-term vesting schedule. After the grant, the reporting person beneficially owns 129,051 common shares, held directly. The Form 4 was signed on 10/07/2025.